TY - JOUR
T1 - Reliability and validity of the Korean version of the European organization for research and treatment of cancer quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy
AU - Kim, Hye Young
AU - Kang, Jeong Hee
AU - Youn, Hyun Jo
AU - So, Hyang Sook
AU - Song, Chi Eun
AU - Chae, Seo Young
AU - Jung, Sung Hoo
AU - Kim, Sung Reul
AU - Kim, Ji Young
PY - 2014/12/1
Y1 - 2014/12/1
N2 - Purpose: This study was performed to assess the reliability and validity of the Korean version of European Organization for Research and Treatment of Cancer Quality of Life Questionnaire - Chemotherapy-induced peripheral neuropathy 20 items (EORTC QLQ-CIPN20) in patients receiving neurotoxic chemotherapy. Methods: A convenience sample of 249 Korean cancer patients, previously or currently, being treated with peripheral neurotoxic chemotherapeutic agents were asked to fill in the questionnaire. Collected data were analyzed using SPSS 21.0 and AMOS 21.0. Construct validity, known-group validity, concurrent validity, and internal consistency reliability of the Korean version of the QLQ-CIPN20 were evaluated. Results: Factor analysis confirmed 3 dimensions of CIPN: sensory, motor, and autonomic. The factor loadings of the 20 items on the 3 subscales ranged from. 38 to. 85. The 3 subscale-model was validated by confirmatory factor analysis (GFI=.90, AGFI=.86, RMSR=.05, NFI=.87, and CFI=.94), and concurrent validity was demonstrated with the EORTC QLQC30. Furthermore, the QLQ-CIPN20 established known-group validity. The Cronbach’s alpha coefficients for internal consistency of the subscales ranged from. 73 to. 89. Conclusion: The Korean version of the EORTC QLQ-CIPN20 showed satisfactory construct, concurrent, and known-group validity, as well as internal reliability.
AB - Purpose: This study was performed to assess the reliability and validity of the Korean version of European Organization for Research and Treatment of Cancer Quality of Life Questionnaire - Chemotherapy-induced peripheral neuropathy 20 items (EORTC QLQ-CIPN20) in patients receiving neurotoxic chemotherapy. Methods: A convenience sample of 249 Korean cancer patients, previously or currently, being treated with peripheral neurotoxic chemotherapeutic agents were asked to fill in the questionnaire. Collected data were analyzed using SPSS 21.0 and AMOS 21.0. Construct validity, known-group validity, concurrent validity, and internal consistency reliability of the Korean version of the QLQ-CIPN20 were evaluated. Results: Factor analysis confirmed 3 dimensions of CIPN: sensory, motor, and autonomic. The factor loadings of the 20 items on the 3 subscales ranged from. 38 to. 85. The 3 subscale-model was validated by confirmatory factor analysis (GFI=.90, AGFI=.86, RMSR=.05, NFI=.87, and CFI=.94), and concurrent validity was demonstrated with the EORTC QLQC30. Furthermore, the QLQ-CIPN20 established known-group validity. The Cronbach’s alpha coefficients for internal consistency of the subscales ranged from. 73 to. 89. Conclusion: The Korean version of the EORTC QLQ-CIPN20 showed satisfactory construct, concurrent, and known-group validity, as well as internal reliability.
KW - Chemotherapy
KW - Peripheral neuropathies
KW - Reliability
KW - Validity
UR - http://www.scopus.com/inward/record.url?scp=84922287655&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84922287655&partnerID=8YFLogxK
U2 - 10.4040/jkan.2014.44.6.735
DO - 10.4040/jkan.2014.44.6.735
M3 - Article
C2 - 25608551
AN - SCOPUS:84922287655
VL - 44
SP - 735
EP - 742
JO - Asian Nursing Research
JF - Asian Nursing Research
SN - 2005-3673
IS - 6
ER -
